Investment Commentary

Introduction Continuing our exploration of GLP-1 weight-loss drugs (GLP-1 Part 1) https://www.baldwinmgt.com/glp-1-weight-loss-drugs-overhyped-or-a-gamechanger/ , we will review recent developments that further boost credibility and excitement about the GLP-1 class of drugs,…

The cost of higher education is a daunting thought for most American families. With the average cost of a public 4-year in-state degree exceeding $156,000 and that of a private…

As a world, we are not getting any younger. This unfortunately is because fertility rates declined sharply from 1971 – 2021 as can be seen in the following chart: CHART…

These quotes from a leading publication give a good picture of the problem… Bubble trouble – the current bubble still has a ways to go. One of the investment services…

Or as it is popularly known, Buy Now Pay Later, is an increasingly used payment scheme which is a modern version of the old layaway plan. Saving for that thing…

Many investors are advised to build an “income portfolio” as they transition into retirement. For those who have seen their investments grow over a lifetime, it may be possible to…

Ozempic, Wegovy, Mountjaro, Zepbound: while not exactly household names like Band-Aid and Kleenex, you likely have heard or read about the exploding popularity of this class of drugs.  We will…

Are we at the top of US stock markets?  Have we missed it if we have money to invest?  Should we wait for a correction, or should we take the…

It was in the early 2000’s that the wind industry, used to generate electricity, started to power homes and reduce hydrocarbons in the air.  Those first-generation machines are now some…

For some time, economic indicators have been telegraphing that the U.S. economy was improving.  But American consumers did not seem to care – at least as reflected by consumer surveys.…